國立虎尾科技大學 |

Experimental Investigations into Sarcomas = Therapy Using Ferromagnetically Induced Cytostatics /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Experimental Investigations into Sarcomas/ by Manfred Georg Krukemeyer.
其他題名:	Therapy Using Ferromagnetically Induced Cytostatics /
作者:	Krukemeyer, Manfred Georg.
面頁冊數:	XII, 122 p. 39 illus., 21 illus. in color.online resource. :
Contained By:	Springer Nature eBook
標題:	Surgical oncology. -
電子資源:	https://doi.org/10.1007/978-3-658-20591-1
ISBN:	9783658205911

Experimental Investigations into Sarcomas = Therapy Using Ferromagnetically Induced Cytostatics /
Krukemeyer, Manfred Georg.

Experimental Investigations into SarcomasTherapy Using Ferromagnetically Induced Cytostatics /[electronic resource] :by Manfred Georg Krukemeyer. - 1st ed. 2018. - XII, 122 p. 39 illus., 21 illus. in color.online resource.

Manfred Georg Krukemeyer first describes magnetic drug targeting, by which is meant the focused application of drugs, e.g. the introduction of a cytostatic, and which is aimed at optimising its locally therapeutic effect. The author thus achieves a high concentration of cytostatic at the site of the tumour. The particles have to be large enough to be attracted by a magnetic field and so find their way into the tumour, where they release their active ingredient. The aim of the hypothesis formed by one of the author’s study groups was to show in a scientific experiment that in this case cytostatics coupled with iron particles [Fe3O4] can be introduced into a tumour. The focused introduction of drugs – magnetic drug targeting – results in faster arrival of the active ingredient at the target site together with a reduced quantity of active substances. For this reason magnetic drug targeting is also interesting from an economic point of view. Contents Sarcomas and their Pathology Magnetic Drug Targeting Animal Testing and Patient Examination, Tumour Therapy in Humans Target groups Researchers, teachers and students in surgical and oncology departments Doctors working in the fields of surgery and oncology About the author Dr. med. Manfred Georg Krukemeyer is a specialist surgeon currently holding a senior position at a large German hospital enterprise.

ISBN: 9783658205911

Standard No.: 10.1007/978-3-658-20591-1doiSubjects--Topical Terms:

1254222
Surgical oncology.

LC Class. No.: RD651-678

Dewey Class. No.: 616.994

Experimental Investigations into Sarcomas = Therapy Using Ferromagnetically Induced Cytostatics /
LDR:02695nam a22003735i 4500 001 995540
003 DE-He213
005 20200703134538.0
007 cr nn 008mamaa
008 201225s2018 gw | s |||| 0|eng d
020 $a 9783658205911 $9 978-3-658-20591-1
024 7 $a 10.1007/978-3-658-20591-1 $2 doi
035 $a 978-3-658-20591-1
050 4 $a RD651-678
072 7 $a MNK $2 bicssc
072 7 $a MED085000 $2 bisacsh
072 7 $a MNK $2 thema
082 0 4 $a 616.994 $2 23
100 1 $a Krukemeyer, Manfred Georg. $e author. $4 aut $4 http://id.loc.gov/vocabulary/relators/aut $3 1286527
245 1 0 $a Experimental Investigations into Sarcomas $h [electronic resource] : $b Therapy Using Ferromagnetically Induced Cytostatics / $c by Manfred Georg Krukemeyer.
250 $a 1st ed. 2018.
264 1 $a Wiesbaden : $b Springer Fachmedien Wiesbaden : $b Imprint: Springer, $c 2018.
300 $a XII, 122 p. 39 illus., 21 illus. in color. $b online resource.
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
347 $a text file $b PDF $2 rda
520 $a Manfred Georg Krukemeyer first describes magnetic drug targeting, by which is meant the focused application of drugs, e.g. the introduction of a cytostatic, and which is aimed at optimising its locally therapeutic effect. The author thus achieves a high concentration of cytostatic at the site of the tumour. The particles have to be large enough to be attracted by a magnetic field and so find their way into the tumour, where they release their active ingredient. The aim of the hypothesis formed by one of the author’s study groups was to show in a scientific experiment that in this case cytostatics coupled with iron particles [Fe3O4] can be introduced into a tumour. The focused introduction of drugs – magnetic drug targeting – results in faster arrival of the active ingredient at the target site together with a reduced quantity of active substances. For this reason magnetic drug targeting is also interesting from an economic point of view. Contents Sarcomas and their Pathology Magnetic Drug Targeting Animal Testing and Patient Examination, Tumour Therapy in Humans Target groups Researchers, teachers and students in surgical and oncology departments Doctors working in the fields of surgery and oncology About the author Dr. med. Manfred Georg Krukemeyer is a specialist surgeon currently holding a senior position at a large German hospital enterprise.
650 0 $a Surgical oncology. $3 1254222
650 0 $a Oncology . $3 1253469
650 1 4 $a Surgical Oncology. $3 673742
650 2 4 $a Oncology. $3 593951
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
776 0 8 $i Printed edition: $z 9783658205904
776 0 8 $i Printed edition: $z 9783658205928
856 4 0 $u https://doi.org/10.1007/978-3-658-20591-1
912 $a ZDB-2-SME
912 $a ZDB-2-SXM
950 $a Medicine (SpringerNature-11650)
950 $a Medicine (R0) (SpringerNature-43714)